ADHD Beyond the Symptoms: Could Red Light Therapy Address the Biology Behind It?

We aren’t making any claims in this article; we are simply sharing research.

‍

‍

Attention-deficit/hyperactivity disorder (ADHD) is often thought of as a childhood condition, but its impact can extend far beyond the school years. ADHD is commonly identified during childhood, with research estimating that it affects around 5% of school-age children worldwide (1). While ADHD has historically been diagnosed more frequently in children, symptoms continue well into adulthood. In fact, research estimates that approximately 2.5% of adults have ADHD (2). And for adults living with the condition, the effects can reach beyond difficulties with attention or hyperactivity. Research has found that adults with ADHD may experience greater challenges in several areas of psychosocial functioning and are more likely to experience additional psychiatric disorders compared with the general population (3). Researchers are also continuing to investigate why ADHD develops and persists, with evidence suggesting that factors such as childhood trauma and even maternal stress during pregnancy may be associated with ADHD onset, severity, and persistence into adulthood (4). Together, these findings paint a much broader picture of ADHD as a condition that can affect people across their lifespan, which raises an important question: Could emerging approaches such as photobiomodulation offer another avenue worth exploring?

‍

‍

Understanding ADHD: What Is It?

Before we dive into potential treatments, let’s see if we can identify what exactly is ADHD? Attention-deficit/hyperactivity disorder (ADHD) is characterized by developmentally inappropriate levels of inattention, hyperactivity, and/or impulsivity that can interfere with everyday life, including school, work, relationships, and social functioning (5). But ADHD is much more complex than simply having trouble paying attention or sitting still. Researchers believe there is no single cause. Instead, ADHD appears to develop through a combination of genetic and environmental factors that can differ from one person to another (6,7). Research has also identified differences in brain networks among children with ADHD, adding to evidence that the condition involves differences in how the brain functions and communicates (8).

‍

Scientists are also exploring whether inflammation and oxidative stress may play a role in ADHD. Studies have reported associations between ADHD and inflammatory markers, immune-related conditions, and oxidative stress, while maternal inflammation during pregnancy has also been associated with an increased likelihood of ADHD in offspring (6). Research has even found significant functional and psychosocial difficulties among adults with ADHD symptoms who had not been clinically diagnosed, suggesting that the impact of ADHD can remain substantial even when the condition goes unrecognized (9). Understanding this complexity is important because it helps explain why researchers continue looking beyond the symptoms themselves to better understand what may be happening within the brain and body of someone with ADHD.

‍

‍

How Is ADHD Diagnosed?

With ADHD affecting people in so many different ways, how do healthcare professionals actually determine whether someone has it? Unlike many medical conditions, ADHD is diagnosed clinically rather than through a single blood test, brain scan, or other biological test. Instead, the diagnostic process relies on evaluating characteristic behavioral symptoms, particularly patterns of inattention, impulsivity, and hyperactivity (10). Researchers have pointed out that this process can sometimes be challenging because ADHD is highly diverse, both in how its symptoms appear and in the underlying biological factors that may be involved (5).

‍

Another challenge is that ADHD doesn't necessarily look the same throughout a person's life. This is one reason ADHD diagnosis involves much more than simply asking whether someone is easily distracted or hyperactive. Clinicians must consider the pattern of symptoms, how those symptoms affect everyday functioning, and how ADHD may present differently across the lifespan (10,11). And because researchers have yet to identify a single biological marker that can definitively diagnose ADHD, careful clinical assessment remains at the heart of identifying the disorder (5).

‍

‍

What Are the Symptoms of ADHD?

ADHD can look different from one person to another, but two of its most recognizable features are difficulty regulating attention and poor impulse control (12). Someone with ADHD may struggle to stay focused on a task, become easily distracted, act before thinking, or have difficulty controlling their responses. Research has linked these challenges in part to the prefrontal cortex (PFC), an area of the brain that plays an important role in the “top-down” regulation of attention, behavior, and emotion and has been reported to be underactive in many people with ADHD (12).

‍

But the effects of ADHD can extend beyond attention and impulsivity. Research has also associated ADHD with cognitive difficulties such as impaired working memory and reduced executive function (13). In everyday life, this may help explain why tasks involving planning, organization, remembering information, shifting between tasks, or maintaining focus can be particularly challenging. Social intrusiveness and decreased inhibition have also been identified as features associated with impulsivity in ADHD (14,15).

‍

Researchers have also investigated behavioral and cognitive changes associated with developmental exposure to inflammation, including difficulty sustaining attention, decreased cognitive flexibility, changes in social behavior, and anxiety-like behavior in experimental models (16,17,18,19,20,21,22). These findings are particularly interesting given the growing research into possible connections between ADHD and inflammatory processes.

‍

Symptoms can persist into adulthood and even older age, but the way they present may change over time (11). In adults, ADHD may involve difficulties with organization, working memory, sustained attention, controlling responses, and completing complex tasks. Mood difficulties, emotional dysregulation, and irritability may also accompany the condition (11). Because these symptoms can overlap with other conditions, researchers emphasize the importance of looking carefully at the individual's overall clinical picture.

‍

Beyond the symptoms we can actually observe, scientists are also studying what may be happening biologically behind the scenes. Research models have explored factors such as mitochondrial dysfunction, oxidative stress, neuroinflammation, neuronal apoptosis, and tau-related changes, as well as depressive-like behavior and cerebral inflammation (23,24). These aren't considered symptoms used to diagnose ADHD, but they may provide researchers with clues about some of the biological pathways involved.

‍

‍

What Factors Can Affect ADHD and What is the Cause?

ADHD is a complex condition, which means there probably isn’t one single factor responsible for how it develops or how strongly its symptoms are experienced. Evidence suggests that ADHD likely develops through a complicated combination of genetic, environmental, developmental, and biological factors. Researchers increasingly describe ADHD as a multifactorial neurodevelopmental condition, with several neurotransmitter systems playing important roles. Dopamine, norepinephrine, and glutamate are involved in regulating attention, alertness, executive function, motivation, and behavioral inhibition. When these systems and their related brain circuits are disrupted, researchers believe they may contribute to some of the hallmark features of ADHD, including inattention, impulsivity, and hyperactivity (5).

‍

Genetics and Family History

One of the strongest pieces of the ADHD puzzle appears to be genetics. Research has shown that ADHD can run in families, suggesting that inherited factors can contribute to a person's likelihood of developing the condition (25,26). However, genetics don't tell the whole story. Rather than there being one single “ADHD gene,” the condition appears to involve multiple genetic influences.

‍

Prenatal Factors

Researchers are also looking much earlier in life, including what happens before a child is even born. Prenatal risk factors have been associated with the later development of ADHD (27), and several factors linked with ADHD share something interesting in common: increased maternal inflammation.

‍

Maternal Infection

Maternal infection, tobacco smoking during pregnancy, fetal alcohol syndrome, and maternal obesity have all been identified as ADHD risk factors and are also associated with an increased maternal inflammatory profile. This overlap has led researchers to investigate whether inflammation during fetal brain development could potentially play a role in ADHD (28,29,30).

‍

Maternal Stress

Maternal stress during pregnancy has also been associated with an increased risk of ADHD in children (31). Again, these associations don't mean that experiencing stress or inflammation during pregnancy automatically causes a child to develop ADHD. Instead, they offer researchers clues about some of the conditions that may influence early brain development.

‍

Prematurity, Low Birth Weight, and Environmental Exposures

Other early-life factors have also been associated with ADHD. Research has identified prematurity and low birth weight, along with exposure to certain environmental toxins and pesticides, as potential risk factors (32). Taken together, these findings reinforce the idea that ADHD may begin with a combination of vulnerabilities rather than one isolated event.

‍

Childhood Trauma and Stressful Life Events

What happens after birth may matter, too. Research has found associations between childhood trauma, stressful life events, and ADHD symptoms. Childhood trauma has been associated with ADHD onset, greater symptom severity, and persistence of ADHD into adulthood (31). Other research has found that stressful life events, particularly childhood trauma, can predict ADHD symptoms and has explored whether negatively biased memory may be one cognitive marker connecting childhood trauma with the development or persistence of symptoms (33). These findings don't mean trauma is responsible for every case of ADHD. Instead, they suggest that stressful experiences may be another piece of the puzzle.

‍

The ADHD-Sleep Connection

Those same biological systems may also connect ADHD to another important factor: sleep and the body's circadian rhythm. The neurotransmitters involved in attention, alertness, motivation, and behavioral regulation don't operate independently from our sleep-wake cycle. In fact, emerging evidence suggests that the neurotransmitter systems involved in ADHD are closely connected with the biological systems that regulate our circadian rhythm, the internal clock that helps determine when we feel awake and when we feel ready to sleep (34).

‍

This connection may help explain why sleep and circadian difficulties are reported so frequently in people with ADHD. Researchers have found evidence of delayed circadian rhythms, differences in melatonin secretion, and disrupted sleep-wake patterns among people with ADHD (35,36,37,38,39). Genetic differences involving certain “clock genes,” along with environmental and neurobiological factors, are also being investigated for their possible contributions to circadian disruption in ADHD (40, 41).

‍

And sleep problems appear to be remarkably common. Research cited in this area suggests that approximately 70% of people with ADHD experience irregular sleep-wake patterns, while around 60% of adults with ADHD screen positive for a sleep disorder. Delayed Sleep Phase Syndrome (DSPS), in which a person's natural sleep and wake times occur significantly later than conventional schedules, has been reported inapproximately 36%, while insomnia has been reported in around 29% (35,42,43).

‍

Why does this matter? Because poor or poorly timed sleep may do much more than leave someone tired the following day. Sleep difficulties can potentially affect attention, mood, impulse control, memory, processing speed, and other aspects of cognitive performance. In children with ADHD, sleep-onset insomnia has been associated with more severe ADHD symptoms as well as difficulties with sustained attention and processing speed (44). Researchers have therefore proposed that circadian and sleep disturbances maybe closely intertwined with ADHD and could potentially worsen daytime symptoms such as inattention, impulsivity, and emotional dysregulation (34,36,45).

‍

The relationship may also connect with other pieces of ADHD biology. Researchers are exploring circadian disruption alongside dopamine regulation, mood, metabolism, substance use disorders, and other conditions commonly associated with ADHD (40). This raises the possibility that sleep and circadian rhythms aren't simply secondary inconveniences but may interact with some of the broader biological systems being investigated in ADHD.

‍

Researchers are also looking at ways to address these disturbances. Both medication-based and non-pharmacological approaches have been studied for sleep problems in children with ADHD, including sleep-hygiene education and other sleep-focused interventions (46). Researchers are additionally investigating chronotherapeutic approaches such as light therapy, melatonin, and behavioral strategies, with the possibility that treatment could eventually become more personalized according to an individual's circadian profile (40).

‍

Importantly, sleep disturbance shouldn't automatically be viewed as a biological “defect” that causes ADHD. The relationship appears to be much more complicated. What the research does suggest is that sleep and circadian disruption may represent an important part of the ADHD picture, with the potential to interact with and worsen symptoms that are already present.

‍

Oxidative Stress

One area researchers have become increasingly interested in is oxidative stress. Our cells naturally produce reactive molecules during normal metabolism, and the body has antioxidant systems that help keep them under control. Oxidative stress occurs when that balance shifts and reactive molecules overwhelm the body's ability to adequately manage them. When this happens in the brain, it may interfere with normal cellular and neuronal function.

‍

Research examining ADHD has reported evidence suggesting that oxidative stress and neuroinflammation may be involved in its underlying biology (32,47,48). Experimental research has also connected cerebral oxidative stress and inflammation with behavioral changes, including depressive-like behavior (24).

‍

Mitochondrial Dysfunction

Mitochondria are responsible for producing much of the energy cells need to function, making them particularly important in energy-demanding organs such as the brain and research has reported evidence of mitochondrial dysfunction in ADHD brains (49).

‍

One particularly interesting laboratory study examined cybrids created using platelets from people with ADHD. Researchers detected mitochondrial defects and suggested that impaired cellular bioenergetics could potentially contribute to ADHD pathology or characteristics (50). 

‍

The Immune System and Inflammation

Several studies have reported differences in inflammatory or immune-related markers among people with ADHD. These include reports of higher serum cytokine levels, increased antibasal ganglia antibodies, and antibodies against the dopamine transporter in some ADHD populations (51,52,53,54,55,56,57). Researchers have described these findings as evidence supporting the possibility that inflammation could be part of a biological pathway involved in ADHD.

‍

And this is where the story gets even more interesting, because scientists aren't only asking whether inflammation exists elsewhere in the body. They're asking whether inflammation involving the brain and nervous system itself could play a role. Research in other neurological and psychiatric conditions gives scientists reason to explore this possibility. For example, research involving depression has examined how sustained stress and prolonged release of pro-inflammatory cytokines may contribute to chronic neuroinflammation, while also interacting with oxidative stress and the hypothalamic-pituitary-adrenal (HPA) stress-response system (58). 

‍

Neuroinflammation

Neuroinflammation refers to inflammatory activity involving the brain and nervous system. Evidence from human research and animal models collectively has led researchers to propose that neuroinflammation may contribute to the pathophysiology of ADHD (32,59,60).

‍

Why would that matter? Neuroinflammation has the potential to influence brain development through several different pathways, including glial activation, increased oxidative stress, altered neuronal development, reduced neurotrophic support, and changes in neurotransmitter function (61,62,63,64,65).

‍

Researchers have also reported behavioral changes in animal models of prenatal inflammation that resemble certain characteristics associated with ADHD. These include difficulty sustaining attention, decreased cognitive flexibility, changes in social behavior, and anxiety-like behavior (16,17,18,19,20,21,22). These studies add another piece to the investigation into how inflammatory activity during development could potentially influence later brain function and behavior.

‍

Dopamine, Serotonin, and Neurotransmitter Function

Another major part of the ADHD story involves the chemical messengers brain cells use to communicate, particularly dopamine and serotonin. Dopamine has long been of interest in ADHD research because of its role in attention, motivation, reward, and behavioral regulation. Evidence supporting dopamine's involvement comes partly from ADHD medications such as methylphenidate and amphetamines, which increase dopamine availability and can temporarily improve ADHD symptoms (66). This provides evidence that dopaminergic signaling is involved in the condition.

‍

Serotonin, also known as 5-HT, may represent another part of the picture. Earlier research reported lower blood levels of 5-HT in children with ADHD (67,68), as well as differences involving serotonin-related binding in blood platelets (69). These observations contributed to the serotonergic hypothesis of ADHD, which proposes that reduced serotonin availability at the synapse could contribute to certain clinical features of the disorder (70). Why might serotonin matter when ADHD is usually associated with attention and hyperactivity? Because ADHD isn't purely a cognitive condition.

‍

Emotional regulation is increasingly recognized as an important component of ADHD (71). ADHD also frequently overlaps with anxiety, and research has reported that children with ADHD have approximately twice the risk of later depression compared with children without ADHD (72). As researchers increasingly recognize ADHD as involving both cognitive and emotional regulation, investigating neurotransmitter systems such as dopamine and serotonin becomes particularly relevant.

‍

These neurotransmitter findings may also connect back to the neuroinflammation discussion. One of the mechanisms through which neuroinflammation has been proposed to influence brain development and function is altered neurotransmitter activity (61). Rather than representing completely separate explanations for ADHD, inflammation, oxidative stress, brain development, and neurotransmitter signaling may therefore be interconnected pieces researchers are still working to understand.

‍

Differences in Brain Development

Researchers have even identified differences in brain development associated with ADHD. Children with ADHD have been reported to have approximately a 4% lower overall gray matter volume across the cerebrum and cerebellum on average (73). Other research found differences in the timing of cortical development, with certain cortical regions reaching peak thickness approximately three years later in children with ADHD (74).

‍

‍

What Treatment Options Are Available for ADHD?

Once ADHD has been diagnosed, what can actually be done about it? There currently isn't a cure for ADHD, but that doesn't mean symptoms can't be managed. Evidence-based treatments can significantly reduce ADHD symptoms and the functional difficulties they create (75). Treatment is often individualized and may include medication, chiropractic care, behavioral and psychosocial interventions, exercise, nutritional approaches, neurofeedback, and other forms of neurostimulation (76). Medication is one of the more established treatments for ADHD, but researchers have investigated a wide variety of non-pharmacological and complementary approaches as well (75,76).

‍

These include cognitive behavioral therapy (CBT)(77), mindfulness-based interventions, yoga, cognitive and metacognitive training, neurofeedback, and parent-training programs (78). Psychosocial support and school-based interventions can provide additional help with the everyday challenges associated with the condition (76). These approaches don't necessarily address ADHD in exactly the same way, but they can provide different tools for managing behavior, emotions, organization, attention, and daily functioning.

‍

Physical exercise, for example, has been studied as a non-pharmacological intervention for ADHD (79), and broader reviews include exercise among the approaches with evidence supporting its use as part of ADHD management (76). Researchers have investigated both medication and non-medication approaches for managing sleep problems in children with ADHD, including sleep-hygiene training and weighted blankets (46). A separate study specifically evaluated weighted blankets for sleep in children with ADHD (80), while good daily sleep hygiene has also been suggested as potentially beneficial in managing ADHD symptoms (81). Even music therapy has entered the conversation, with researchers exploring its potential as an alternative intervention for children with ADHD (82).

‍

Nutrition

The relationship between nutrition, the gut, and ADHD is another developing area of research. Reviews of ADHD treatments include nutrition and dietary supplements among the complementary approaches being investigated (76), while researchers are also studying possible relationships between the gut microbiome and neurodevelopmental conditions such as ADHD (83). One recent study even investigated kefir and its effects on ADHD symptoms, sleep, and the gut microbiota in children (84). Omega-3 fatty acids have also received considerable attention. Research has investigated omega-3 supplementation for ADHD (85), and these fatty acids are particularly interesting because of their documented anti-inflammatory properties (86).

‍

Chiropractic

Chiropractic care has also been explored as an approach for ADHD. A 2012 case report followed a 5-year-old child with ADHD-associated symptoms who received chiropractic care over a one-year period. Treatment included spinal manipulation, with particular attention to areas of joint restriction and muscular tension. Over the course of treatment, the child's parents reported improvements in acting-out behaviors, concentration, ability to follow instructions, and performance at home and school. The authors concluded that the subjective improvements suggested chiropractic care may warrant further investigation for patients with ADHD. (87)

‍

It was stated,

 “Over the course of a 1-year treatment period, subjective improvement was noted in the behavioral patterns and ADHD-associated symptoms in a 5-year-old patient who was treated with chiropractic care. This suggests that there may be a role for chiropractors in the treatment of patients with ADHD.” (87)

‍

Another interesting case report explored whether cervical spine alignment might have a relationship with ADHD symptoms. In this 2004 report, a 5-year-old child diagnosed with ADHD had previously been treated with several medications without reported success. The child then received 35 chiropractic treatments over eight weeks, during which researchers documented a change in cervical alignment from a 12-degree C2–C7 kyphosis to a 32-degree C2–C7 lordosis. During the course of chiropractic care, the child's facial tics reportedly resolved and behavior substantially improved. After 27 visits, the child's pediatrician determined that the child no longer exhibited ADHD symptoms, and medication was subsequently discontinued. The authors proposed that the structural and functional changes might have been related to correction of the cervical kyphosis and suggested that this possible connection deserved further investigation. (88)

‍

While research is still limited, these early case reports offer encouraging evidence that chiropractic care may be a promising complementary approach worth further investigation for individuals with ADHD.

‍

Neurofeedback and Brain Stimulation

Researchers are also experimenting with approaches that interact more directly with brain activity. Neurofeedback and neurostimulation are both included among approaches being studied for ADHD (76,78). One example is transcranial direct current stimulation (tDCS), which uses a weak electrical current applied through electrodes on the scalp to influence brain activity. Researchers have investigated tDCS as a possible alternative intervention for ADHD (89).

‍

Another approach is repetitive transcranial magnetic stimulation (rTMS). Rather than using light or medication, rTMS uses magnetic pulses to influence activity in targeted areas of the brain. Research has examined its effects in ADHD as another potential neuromodulation strategy (90). These technologies are particularly interesting because they represent a very different way of thinking about ADHD treatment: rather than focusing solely on managing behavior from the outside, researchers are investigating whether it may be possible to influence some of the neural activity associated with the condition itself.

‍

Researchers continue to investigate interventions that address ADHD from very different angles, from behavior and lifestyle to nutrition, spinal care, and the activity of the brain itself (75,76,78). But that raises another interesting possibility. What if, rather than focusing exclusively on individual symptoms, researchers could influence some of the underlying cellular and neurological processes associated with ADHD?

‍

‍

How Does Photobiomodulation Fit Into the ADHD Picture?

‍

Rather than looking only at the outward symptoms of ADHD, PBMT research allows us to ask a different question: Could light influence some of the underlying biological processes that researchers believe may be altered in ADHD?

‍

In this 2025 study, they investigated PBMT in spontaneously hypertensive rats (SHRs), an established animal model used in ADHD research. Researchers specifically evaluated whether PBMT could affect two core ADHD-related behaviors, impulsivity and hyperactivity, while also examining neuroinflammation, neuronal integrity, and connectivity within the brain (91). The results show that PBMT reduced impulsivity and hyperactivity in the animals while also reducing neuroinflammation, preserving neuronal structure and function, and improving neuronal connectivity (91). The researchers concluded that their findings suggest PBMT could represent a promising nonpharmacological intervention for ADHD (91).

‍

‍

Can Light Actually Reach the Brain?

Of course, none of this matters if the light can't get where researchers want it to go. That leads to one of the most important questions in transcranial PBMT research: Can red and near-infrared light penetrate the tissues of the head and reach underlying brain tissue? Research suggests that the amount varies considerably depending on many factors to include wavelength.

‍

One review examining red and near-infrared wavelengths compared wavelengths from 630nm to 810nm and found substantial differences in penetration. In the studies they reviewed, penetration through the human scalp and skull ranged from approximately 0.2% to 10%. Within that research, 808nm and 810nm near-infrared light showed particularly interesting penetration characteristics above the other wavelengths tested. (92)

‍

Another investigation of PBMT reported that 54% of 810nm near-infrared light passed through the prefrontal area in the experimental model studied. Researchers also noted that neural tissue contains large amounts of mitochondrial cytochrome c oxidase (CCO), helping explain why red and near-infrared wavelengths have attracted attention for brain PBMT applications (93).

Another study comparing wavelengths found 660nm & 810nm performed better than any other wavelengths tested for penetration with much stronger, deeper and wider photon penetration into cerebral tissue (94). In other words, the research supports investigating both red and near-infrared wavelengths, while 808/810 nm has received considerable attention in transcranial PBMT research (92,93,94).

‍

‍

Connecting the Dots: Could PBMT Address Processes Associated With ADHD, therefore addressing ADHD as a whole?

If ADHD is associated with changes in these biological processes, what does the research tell us about PBMT's ability to influence those same processes? Earlier, we identified several biological and functional differences researchers have associated with ADHD. The fascinating part is that many of these same areas have independently become targets of photobiomodulation research.

‍

Mitochondria, CellularEnergy, and Oxidative Stress

We previously discussed research suggesting mitochondrial dysfunction and oxidative stress may be involved in ADHD. That's particularly relevant to PBMT because mitochondria are considered an important target of photobiomodulation. Research has investigated PBMT for its ability to influence mitochondrial function and integrity while reducing oxidative stress and neuroinflammation (95).

‍

In one particular study, PBMT helped restore normal mitochondrial dynamics, protected mitochondrial membrane potential, reduced mitochondrial DNA oxidation, and increased cytochromec oxidase activity and ATP production, essentially supporting several processes involved in healthy cellular energy production. Treatment also reduced oxidative damage, inflammation, and several other forms of cellular injury. (23)

‍

 The researchers concluded,

“By alleviating a broad spectrum of Aβ-induced pathology that includes mitochondrial dysfunction, ...LLI could represent a new promising therapeutic strategy for AD.” (23)

‍

This study provides compelling mechanistic evidence that PBMT can influence mitochondrial function and cellular energy production.

‍

Another study combined PBMT with coenzyme Q10 (CoQ10) and investigated its effects on depressive-like behavior, cerebral oxidative stress, inflammation, and apoptosis in an animal stress model. Researchers reported reductions in oxidative stress and neuroinflammatory responses, along with changes in inflammatory signaling and stress-related markers (24,96). There is also evidence that PBMT can influence ATP, the cellular energy produced by mitochondria. In an experimental brain-injury model, researchers proposed that the protective effects of low-level laser therapy may be related to enhanced ATP production and selective modulation of proinflammatory mediators. Treatment also suppressed expression of proinflammatory cytokines including IL-1β and IL-6 (97).

‍

Neuroinflammation

As we discussed earlier, evidence from human and animal research has led scientists to investigate whether neuroinflammation contributes to the pathophysiology of ADHD. Some studies have also reported higher inflammatory markers among people displaying ADHD symptoms.

‍

PBMT, meanwhile, has been investigated specifically for its effects on neuroinflammation. In nervous-system models, low-level light therapy has been associated with modulation of inflammation, prevention of cell death, and promotion of neurogenesis (98). In a spinal cord injury model, PBMT inhibited activation of neurotoxic microglia and astrocytes, reduced neuroinflammation and tissue apoptosis, increased neuronal preservation, and was associated with improved motor recovery (99).

‍

Other research has found that PBMT altered the neuroinflammatory profile of both young and aged rat brains while also improving spatial learning and memory (100). PBMT has also been investigated for its ability to inhibit neuroinflammation and oxidative stress while supporting mitochondrial function (95).

‍

Learning, Memory, and Neuroplasticity

ADHD can also involve difficulties with working memory, executive function, sustained attention, and other cognitive processes. Here again, PBMT research provides some intriguing clues. PBMT has been associated with improvements in spatial learning and memory alongside changes in neuroinflammatory activity (100).

‍

Other experimental research has investigated PBMT's effects on behavioral deficits and neurogenesis, the process through which new neurons are generated, and these findings provide strong support for the promising therapeutic effect of PBMT on neuronal repair (101). In a different neurological disease model, PBMT was associated with improvements in memory loss as well as neuronal degeneration, dendritic spine damage, and synaptic loss (102). What this shows is that PBMT is being investigated for its influence on several processes important to healthy neuronal function, learning, memory, and communication between brain cells.

‍

Depression, Anxiety, and Emotional Function

Emotional dysregulation and co-occurring mental health difficulties can also be part of the larger clinical picture. PBMT has separately been investigated in research involving major depression and anxiety with promising results (103). Experimental work has also explored whether PBMT may alleviate depression and anxiety-related behaviors through effects on mitochondrial function, oxidative stress, and neuroinflammation, and has shown to be an effective method (95).

‍

In the animal stress study combining PBMT with CoQ10, researchers reported improvements in depressive-like behavior along with reductions in cerebral oxidative stress and neuroinflammation. The study also reported decreases in stress and inflammatory markers including cortisol, corticosterone, TNF-α, and IL-6 (24,96). These findings show that PBMT research extends into cognitive and emotional processes that may be relevant to the broader difficulties experienced by some people with ADHD. 

‍

‍

Conclusion: A Promising Direction for ADHD Research

ADHD is far more complex than simply having difficulty paying attention. As the research we've explored throughout this article shows, the condition may involve changes in brain activity and connectivity, mitochondrial function, cellular energy production, oxidative stress, neuroinflammation, cognitive function, emotional regulation, and sleep and circadian rhythms. That complexity is exactly what makes photobiomodulation such an intriguing area of research.

‍

Rather than focusing on only one symptom or biological pathway, PBMT has been studied for its ability to influence several of the same processes researchers are investigating in ADHD. Research has associated PBMT with improved mitochondrial function and ATP production, modulation of neuroinflammation and oxidative stress, support for neuronal health, and effects on brain networks involved in cognitive and emotional function. Even more encouraging, early research using an ADHD animal model has reported improvements in impulsivity and hyperactivity alongside reduced neuroinflammation and improved neuronal connectivity (91).

‍

Direct human research specifically addressing ADHD remains limited but the research we have so far gives us compelling reasons to continue investigating it. PBMT doesn't simply overlap with one area of ADHD research. It intersects with multiple biological pathways that may matter to the condition, making it an especially interesting nonpharmacological approach for future study.

‍

We aren't here to make claims or promise outcomes. We're here to follow the research. And when it comes to ADHD and photobiomodulation, the research is certainly giving us a reason to keep turning the page.

 

 

 

‍